Notably, in endocrine-related cancers, such as breast cancer, ovarian epithelial tumors, endometrial cancer, adrenocortical carcinoma, and prostate cancer, we find frequent amplification of the MEP50 locus (Supplementary Fig. S1B). The gene discussed is WDR77; the disease is breast cancer.